Current knowledge of risk factors for testicular germ cell tumors.

Abstract

The development of the human gonads is tightly regulated by the correct sequential expression of many genes and hormonal activity. Disturbance of this regulation does not only prevent proper development of the gonads, but it also contributes to the development of testicular germ cell tumors. Recent genetic studies, especially genome-wide association studies, have made great progress in understanding genetic susceptibility. Although there is strong evidence of inherited risks, many environmental factors also contribute to the development of testicular germ cell tumors. Histopathological studies have shown that most testicular germ cell tumors arise from germ cell neoplasia in situ, which is thought to be arrested and transformed primordial germ cells. Seminoma has features identical to germ cell neoplasia in situ or primordial germ cells, whereas non-seminoma shows varied differentiation. Seminomas and embryonic cell carcinomas have the feature of pluripotency, which is thought to be the cause of histological heterogeneity and mixed pathology in testicular germ cell tumors. Testicular germ cell tumors show high sensitivity to chemotherapies, but 20-30% of patients show resistance to standard chemotherapy. In the present review, the current knowledge of the epidemiological and genomic factors for the development of testicular germ cell tumors is reviewed, and the mechanisms of resistance to chemotherapies are briefly mentioned.

• Authors: Tomoya Fukawa, Hiro-Omi Kanayama
• Journal: International journal of urology : official journal of the Japanese Urological Association (Int J Urol) Vol. 25 Issue 4 Pg. 337-344 (04 2018) ISSN: 1442-2042 [Electronic] Australia
• PMID: 29345008 (Publication Type: Journal Article, Review)
• Copyright: © 2018 The Japanese Urological Association.

Chemical References

• Antineoplastic Agents, Hormonal

Topics

• Antineoplastic Agents, Hormonal (pharmacology, therapeutic use)
• Drug Resistance, Neoplasm (genetics)
• Gene Expression Regulation, Developmental
• Gene Expression Regulation, Neoplastic
• Genome-Wide Association Study
• Humans
• Incidence
• Male
• Neoplasm Recurrence, Local (epidemiology, prevention & control)
• Neoplasms, Germ Cell and Embryonal (drug therapy, epidemiology, genetics, pathology)
• Risk Factors
• Seminoma (drug therapy, epidemiology, genetics, pathology)
• Testicular Neoplasms (drug therapy, epidemiology, genetics, pathology)
• Testis (cytology, growth & development, pathology)
• Treatment Outcome